NCT00380965View on ClinicalTrials.gov

Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Chemotherapy-Induced Neuropathy

PHASE4CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Peripheral NeuropathyAntineoplastic Combined Chemotherapy Protocols
Interventions
DRUG

Cesamet™ (nabilone)

Trial Locations (2)

33180

South Florida Medical Research, Aventura

34108

Naples Anesthesia and Pain Associates, Naples

Sponsors
All Listed Sponsors
lead

NEMA Research, Inc.

INDUSTRY

NCT00380965 - Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Chemotherapy-Induced Neuropathy | Biotech Hunter | Biotech Hunter